Cargando…
SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1
BACKGROUND: Programmed death-ligand 1 (PD-L1) is a T-cell inhibitory checkpoint molecule that suppresses antitumor immunity. Anti-PD-L1 antibodies have shown remarkable promise in treating tumors, but the patient response rate is low. Therefore, small-molecule checkpoint inhibitors blocking PD-L1 fu...
Autores principales: | Zhang, Na, Dou, Yueying, Liu, Lu, Zhang, Xin, Liu, Xiaojia, Zeng, Qingxuan, Liu, Yang, Yin, Mingxiao, Liu, Xiujun, Deng, Hongbin, Song, Danqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414307/ https://www.ncbi.nlm.nih.gov/pubmed/30711516 http://dx.doi.org/10.1016/j.ebiom.2019.01.054 |
Ejemplares similares
-
Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP(L) in hepatocellular carcinoma
por: Zhang, Na, et al.
Publicado: (2018) -
Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
por: Liu, Yang, et al.
Publicado: (2020) -
Lysosomal dysfunction and autophagy blockade contribute to IMB-6G-induced apoptosis in pancreatic cancer cells
por: Liu, Lu, et al.
Publicado: (2017) -
Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR
por: Liu, Xiaojia, et al.
Publicado: (2021) -
Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3
por: Liu, Lu, et al.
Publicado: (2018)